Comparison of integrated PET-CT remediastinoscopy to restage IIIA-N2 NSCLC after induction chemotherapy Source: ISSN=ISSN 1810-6838, ISBN=, page=289 Year: 2007
The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy Source: Annual Congress 2011 - General thoracic surgery II Year: 2011
PET scan in stage IA lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 436s Year: 2007
Effectiveness of PET scan in postoperative long term follow up of patients with nonsmall cell lung cancer Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008
Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006
Combining bronchoscopy and PET for assessment and staging of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 678s Year: 2005
Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016
Concurrent WBBS and FDG-PET and primary staging of NSCLC, a retrospective analysis Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009
FDG-PET is superior to conventional CT in predicting histologic responses after induction therapy for locally advanced NSCLC Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Could 18 F-FDG PET repeated within cycle 1 predicts objective response to chemotherapy in advanced non-small cell lung cancer (NSCLC)? A pilot study results Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Retrospective assessment of non small cell lung cancer stage IIIA-IIIB, treated with neoadjuvant chemotherapy Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 664s Year: 2007
PET scanning poorly predicts response to pre-operative chemotherapy in non-small cell lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=54 Year: 2004
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Study to assess the utility of head CT in the staging of lung cancer in the post-PET era Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
The role of PET/CT in lung cancer staging Source: Annual Congress 2011 - General thoracic surgery II Year: 2011
Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) Source: Eur Respir J 2004; 24: Suppl. 48, 457s Year: 2004
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017 Year: 2017